265 related articles for article (PubMed ID: 28516885)
21. Successful treatment of renal tubular acidosis and recurrent secondary struvite kidney stones with rituximab in a patient with primary Sjögren's syndrome.
Schilcher G; Schwarz C; Hermann J
Rheumatology (Oxford); 2017 Mar; 56(3):498-500. PubMed ID: 28031439
[No Abstract] [Full Text] [Related]
22. Clinical features and outcomes from the Singapore Sjögren's syndrome study.
Kam JK; Charan N; Leong RW; Loh ZW; Thong BY
Lupus; 2021 Feb; 30(2):248-255. PubMed ID: 33259751
[TBL] [Abstract][Full Text] [Related]
23. Critical hypokalemic renal tubular acidosis due to Sjögren's syndrome: association with the purported immune stimulant echinacea.
Logan JL; Ahmed J
Clin Rheumatol; 2003 May; 22(2):158-9. PubMed ID: 12740687
[No Abstract] [Full Text] [Related]
24. Optimizing conventional DMARD therapy for Sjögren's syndrome.
van der Heijden EHM; Kruize AA; Radstake TRDJ; van Roon JAG
Autoimmun Rev; 2018 May; 17(5):480-492. PubMed ID: 29526636
[No Abstract] [Full Text] [Related]
25. Will targeting B cells be the answer for Sjögren's syndrome?
Looney RJ
Arthritis Rheum; 2007 May; 56(5):1371-7. PubMed ID: 17469093
[No Abstract] [Full Text] [Related]
26. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
Fox RI; Dixon R; Guarrasi V; Krubel S
Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
[TBL] [Abstract][Full Text] [Related]
27. Treatment approaches in primary Sjogren syndrome.
Vissink A; Kallenberg CG; Bootsma H
JAMA; 2010 Nov; 304(18):2015-6; author reply 2016. PubMed ID: 21063008
[No Abstract] [Full Text] [Related]
28. Methotrexate in primary Sjögren's syndrome.
Skopouli FN; Jagiello P; Tsifetaki N; Moutsopoulos HM
Clin Exp Rheumatol; 1996; 14(5):555-8. PubMed ID: 8913659
[TBL] [Abstract][Full Text] [Related]
29. Dramatic effect of hydroxychloroquine on lupus alopecia.
Igari S; Yamamoto T
J Dermatol; 2018 Feb; 45(2):194-197. PubMed ID: 29068087
[TBL] [Abstract][Full Text] [Related]
30. Combination Cyclophosphamide/Glucocorticoids Provide Better Tolerability and Outcomes versus Glucocorticoids Alone in Patients with Sjogren's Associated Chronic Interstitial Nephritis.
Shen Y; Xie J; Lin L; Li X; Shen P; Pan X; Ren H; Chen N
Am J Nephrol; 2017; 46(6):473-480. PubMed ID: 29241210
[TBL] [Abstract][Full Text] [Related]
31. Multicentric reticulohistiocytosis associated with Sjögren's syndrome.
Morris-Jones R; Walker M; Hardman C
Br J Dermatol; 2000 Sep; 143(3):649-50. PubMed ID: 10971349
[No Abstract] [Full Text] [Related]
32. [Primary Gougerot-Sjögren syndrome with necrotizing polymyositis: favorable effect of hydroxychloroquine].
Ponge T; Mussini JM; Ponge A; Forgeau Y; Barrier J; Cottin S; Grolleau JY
Rev Neurol (Paris); 1987; 143(2):147-8. PubMed ID: 3602794
[TBL] [Abstract][Full Text] [Related]
33. Hydroxycholoroquine-induced hyperpigmentation.
Mir A; Boyd KP; Meehan SA; McLellan B
Dermatol Online J; 2013 Dec; 19(12):20723. PubMed ID: 24365014
[TBL] [Abstract][Full Text] [Related]
34. [Changes in taste and smell caused by hydroxychloroquine].
Weber JC; Alt M; Blaison G; Welsch M; Martin T; Pasquali JL
Presse Med; 1996 Feb; 25(5):213. PubMed ID: 8729384
[No Abstract] [Full Text] [Related]
35. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
[TBL] [Abstract][Full Text] [Related]
36. Juvenile onset of primary Sjögren's syndrome: report of 10 cases.
Ostuni PA; Ianniello A; Sfriso P; Mazzola G; Andretta M; Gambari PF
Clin Exp Rheumatol; 1996; 14(6):689-93. PubMed ID: 8978969
[TBL] [Abstract][Full Text] [Related]
37. Sjögren's syndrome: treatment with D-penicillamine and hydroxychloroquine.
Lakhanpal S; Duffy J; Griffing WL; Conn DL; Luthra HS
J Rheumatol; 1985 Oct; 12(5):1028-9. PubMed ID: 4087260
[No Abstract] [Full Text] [Related]
38. Sensorineural hearing loss as the first manifestation of Sjögren's syndrome.
Almeida RS; Oliveira AA; Pego PM; Abuowda Y; Gaspar I; Costa JM
Rev Assoc Med Bras (1992); 2017 Jan; 63(1):7-9. PubMed ID: 28225872
[No Abstract] [Full Text] [Related]
39. [Sjögren's syndrome: a new approach to treatment].
Rossier V; Bart PA; Spertini F
Rev Med Suisse; 2012 Apr; 8(337):843-7. PubMed ID: 22594008
[TBL] [Abstract][Full Text] [Related]
40. Maintenance of rituximab treatment in a patient with primary Sjögren's syndrome.
Lehner GF; Brunner-Palka M; Rettenbacher T; Schmidauer R; Herold M
Rheumatology (Oxford); 2014 Jul; 53(7):1349-50. PubMed ID: 24446469
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
